Antacids

Antacids

Global Antacids Market to Reach US$7.9 Billion by 2030

The global market for Antacids estimated at US$6.8 Billion in the year 2023, is expected to reach US$7.9 Billion by 2030, growing at a CAGR of 2.2% over the analysis period 2023-2030. Proton Pump Inhibitors, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$2.2 Billion by the end of the analysis period. Growth in the H2 Antagonist segment is estimated at 2.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.8 Billion While China is Forecast to Grow at 4.8% CAGR

The Antacids market in the U.S. is estimated at US$1.8 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 4.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.5% and 1.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.1% CAGR.

Global Antacids Market - Key Trends and Drivers Summarized

Antacids are over-the-counter medications used to neutralize stomach acid and relieve symptoms of heartburn, acid reflux, and gastroesophageal reflux disease (GERD). They work by raising the pH level in the stomach, thereby reducing the acidity and alleviating the discomfort associated with indigestion and sour stomach. Common ingredients in antacids include magnesium hydroxide, aluminum hydroxide, calcium carbonate, and sodium bicarbonate. Each of these compounds works slightly differently, but all serve the same basic function of acid neutralization. Antacids are available in various forms, including tablets, capsules, liquids, and powders, making them versatile and convenient for consumers to use. They are often the first line of defense against occasional stomach discomfort and are popular due to their rapid action and availability.

The market for antacids has evolved over time with advances in pharmaceutical formulations enhancing the effectiveness and user experience of these products. Recent developments include the combination of antacids with alginate, which not only neutralizes stomach acid but also forms a physical barrier that prevents acid from rising back into the esophagus. There is also a growing trend towards natural and organic antacid alternatives that use herbal ingredients such as ginger, turmeric, and licorice root, which appeal to health-conscious consumers looking for gentler options. Additionally, manufacturers have been focusing on improving the flavor and texture of antacid products, which can often be a barrier to compliance for many users. These improvements are designed to make products more palatable and easier to ingest, which is particularly important for elderly patients and others who may have difficulties with conventional formulations.

The growth in the antacids market is driven by several factors, including an increase in gastrointestinal disorders among the global population, lifestyle changes, and enhanced consumer awareness of over-the-counter remedies for digestive health. Dietary habits that include high consumption of spicy foods, caffeine, and alcohol contribute to the prevalence of acidity and heartburn, fueling demand for antacid products. Additionally, the growing elderly population, which is more prone to digestive issues due to physiological changes with aging, also contributes to the expansion of this market. Consumer behavior has shifted towards self-medication and preventive health management, further bolstering the sales of antacids. Furthermore, innovations in product formulations that offer faster relief and fewer side effects, along with aggressive marketing strategies and broad distribution channels, have made antacids highly accessible and popular among consumers. Regulatory support for over-the-counter antacid products also plays a crucial role in ensuring their safety and efficacy, maintaining consumer trust and driving market growth. Together, these factors depict a robust market that continues to adapt and thrive in response to changing consumer needs and health trends.

Select Competitors (Total 54 Featured) -

• AdvaCare Pharma
• Alkem Laboratories Ltd.
• Bayer AG
• Bhumi Pharmaceuticals
• Cipla Inc
• Haleon Plc
• GCP Laboratories
• Mylanta (A brand of McNeil Consumer Pharmaceuticals Company)
• Nestle New Zealand Ltd.
• Novartis AG
• Pfizer Inc
• Reckitt Benckiser Group PLC
• Rolaids (A brand of Procter & Gamble)
• SPI Pharma
• Tums (A brand of Haleon)
• ;

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.